Evaluation of depression and anxiety in a phase 3, double-blind, placebo-controlled trial of the neuroactive steroid GABAA receptor positive allosteric modulator SAGE-217 in postpartum depression

The requested reference [e309adb24a666bf68b21ef498fd949ef65fee159] no longer exists in our database. It has been replaced by the current reference: [28fbdc530347fcd34b628651d6327d3fe3c5278d]

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2019
This article has no abstract
Epistemonikos ID: cad90faf1c28ab0c64ea2f1402c8ff084168af99
First added on: Apr 29, 2026